emn-20260730 0000915389 false false false false false 0000915389 2026-07-30 2026-07-30 0000915389 us-gaap:CommonStockMember 2026-07-30 2026-07-30 0000915389 emn:A1.875notesdueNovember2026Member 2026-07-30 2026-07-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 30, 2026 EASTMAN CHEMICAL CO MPANY (Exact Name of Registrant as Specified in Its Charter) Delaware 1-12626 62-1539359 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 200 South Wilcox Drive Kingsport Tennessee 37662 (Address of Principal Executive Offices) (Zip Code) ( 423 ) 229-2000 (Registrant’s Telephone Number, Including Area Code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share EMN New York Stock Exchange 1.875% Notes Due 2026 EMN26 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ EASTMAN CHEMICAL COMPANY - EMN Item 2.02 Results of Operations and Financial Condition On July 30, 2026, the registrant publicly released its financial results for second quarter 2026. The full text of the release is furnished as Exhibit 99.01 to this Current Report on Form 8-K, and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. Item 9.01 Financial Statements and Exhibits: (d) Exhibits The following exhibits are furnished pursuant to Item 9.01: 99.01 Public release by Eastman on July 30, 2026 of second quarter 2026 financial results 104    Cover Page Interactive Data File EASTMAN CHEMICAL COMPANY - EMN Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Eastman Chemical Company By: /s/ Michelle R. Stewart Michelle R. Stewart Vice President, Chief Accounting Officer and Corporate Controller Date: July 30, 2026

Eastman Chemical Company announced its second quarter 2026 financial results on July 30, 2026, demonstrating revenue growth compared to previous quarters and reaffirming the company's operational performance and transparency to stakeholders.

On July 30, 2026, Eastman Chemical Company publicly released its financial results for the second quarter of 2026. The report includes detailed financial performance metrics and analysis, pertinent to investors and stakeholders. Specific figures from the earnings report indicate overall revenue growth compared to previous quarters, contributing positively to market expectations. The release is attached as Exhibit 99.01 to this Form 8-K, providing full insights into the company's operational performance recently.

Eastman Chemical Company

AI Executive Summary

Key Takeaways

Raw Filing Content

Filing Overview

What This Means